Martin Gouldstone
Chief Executive Officer bei ONCIMMUNE HOLDINGS PLC
Vermögen: 10 420 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Martin Gouldstone
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 14 | |
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
Public Company | Miscellaneous Commercial Services | 9 | |
Public Company | Pharmaceuticals: Major | 8 | |
Public Company | Miscellaneous Commercial Services | 8 | |
BDO UK LLP
BDO UK LLP Miscellaneous Commercial ServicesCommercial Services BDO UK LLP provides tax, audit & assurance, advisory and business outsourcing services. The private company is based in London, UK.
5
| Private Company | Miscellaneous Commercial Services | 5 |
Sareum Ltd.
Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK
2
| Subsidiary | Drugstore Chains | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Martin Gouldstone
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal | |
RESMED, INC. | Medical Specialties | Director of Finance/CFO | |
Viventia Biotech, Inc.
Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Biotechnology | Director/Board Member | |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Miscellaneous Commercial Services | Director/Board Member | |
SAREUM HOLDINGS PLC | Miscellaneous | Chairman Chairman | |
ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Director/Board Member | |
Cocoon Biotech, Inc.
Cocoon Biotech, Inc. BiotechnologyHealth Technology Cocoon Biotech, Inc. develops and manufactures medicines for osteoarthritis patients. The company was founded by Ailis Tweed-Kent in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Vium, Inc.
Vium, Inc. Information Technology ServicesTechnology Services Vium, Inc. provides technology for preclinical drug discovery services. It offers biomedical investigators with technology that accelerates the preclinical drug discovery and development pipeline. The company was founded by Timothy L. Robertson and Jonathan Betts-Lacroix in 2013 and is headquartered in San Mateo, CA. | Information Technology Services | Chairman | |
SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
University of Oxford | College/University | Doctorate Degree Doctorate Degree Director/Board Member Doctorate Degree Undergraduate Degree | |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree Undergraduate Degree | |
University of Cambridge | College/University | Graduate Degree Undergraduate Degree | |
PHYSIOMICS PLC | Miscellaneous Commercial Services | Chairman Chairman | |
University of California, Los Angeles | College/University | Masters Business Admin | |
The University of Edinburgh | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
British Heart Foundation | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
INSEAD | College/University | Masters Business Admin | |
Trinity College Dublin | College/University | Undergraduate Degree | |
London School of Hygiene & Tropical Medicine | College/University | Corporate Officer/Principal | |
The University of Nottingham | College/University | Director of Finance/CFO Undergraduate Degree | |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Women's Forum, Inc.
Women's Forum, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Leadership Foundations, Women's Forum, Inc. is a non-profit community for women leaders of diverse achievement. The private company is based in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The European Commission | General Government | Corporate Officer/Principal | |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Maven Capital Partners UK LLP
Maven Capital Partners UK LLP Investment ManagersFinance Maven Capital Partners UK LLP (Maven Capital Partners) is a private equity subsidiary of Mattioli Woods PLC founded in 1986. The firm is headquartered in Manchester, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Analyst | |
ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
St Bartholomew's Hospital Medical College | College/University | Doctorate Degree | |
DIMENSION THERAPEUTICS INC | Biotechnology | Chief Executive Officer | |
ViCentra BV
ViCentra BV Electronic Equipment/InstrumentsElectronic Technology ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands. | Electronic Equipment/Instruments | Director of Finance/CFO | |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Chairman | |
PlaqueTec Ltd.
PlaqueTec Ltd. Miscellaneous Commercial ServicesCommercial Services PlaqueTec Ltd. develops a liquid biopsy system platform technology that provides unparalleled resolution of the biological processes that cause coronary artery disease. The firm’s Liquid Biopsy System addresses the underlying biomarker collection problems preventing advances in CAD research. The company was founded by Stephen Blatcher in 2000 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
MedCity Ltd. | Director/Board Member | ||
iOX Therapeutics Ltd.
iOX Therapeutics Ltd. BiotechnologyHealth Technology iOX Therapeutics Ltd. provides cancer therapeutics services. The company was founded by Vincenzo Cerundolo in February 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
AVROBIO, INC. | Biotechnology | Director/Board Member | |
HEALTHBEACON PLC | Packaged Software | Director/Board Member | |
Thrombolytic Science International LLC
Thrombolytic Science International LLC Pharmaceuticals: MajorHealth Technology Thrombolytic Science International LLC operates as a vascular medicine and biotech company. The company was founded by Alexis Wallace and Victor Gurewich and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
PhESi LLC
PhESi LLC Pharmaceuticals: MajorHealth Technology PhESi LLC provides drug and clinical development services for life sciences companies. The private company is based in East Lyme. | Pharmaceuticals: Major | Director/Board Member | |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AOBiome Therapeutics, Inc. develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions. Its portfolio includes three clinical-stage programs, a Phase 2b study to treat patients with acne vulgaris, a Phase 2 trial to reduce elevated blood pressure, and a Phase 1b/2a clinical trial in allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. The company was founded by Jamie Heywood, David Whitlock and Lenny Barshack in 2013 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member | |
Open Orphan DAC
Open Orphan DAC Packaged SoftwareTechnology Services Open Orphan DAC develops platform for pharmaceutical and biotechnology companies seeking to commercialize their products across Europe. It focuses on building its database of over 500 pharmaceutical companies with orphan drugs either approved or advancing through clinical trials. The company is headquartered in Ballsbridge, Ireland. | Packaged Software | Chief Executive Officer Chairman | |
POOLBEG PHARMA PLC | Pharmaceuticals: Major | Founder Director/Board Member Director of Finance/CFO General Counsel |
Statistik
International
Vereinigtes Königreich | 23 |
Vereinigte Staaten | 18 |
Irland | 5 |
Kanada | 3 |
Niederlande | 3 |
Sektoral
Health Technology | 23 |
Consumer Services | 11 |
Commercial Services | 8 |
Technology Services | 4 |
Health Services | 3 |
Operativ
Director/Board Member | 223 |
Corporate Officer/Principal | 77 |
Chairman | 53 |
Chief Executive Officer | 37 |
Director of Finance/CFO | 35 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Annalisa Jenkins | 51 |
Timothy Bunting | 38 |
Stephen Parker | 32 |
Vishal Kumar Gulati | 27 |
Stella Panu | 25 |
Paul Harper | 20 |
Paul Rudd Drayson | 20 |
Alistair Macdonald | 18 |
Brendan Buckley | 16 |
Elaine Sullivan | 15 |
Sally Christina Waterman | 15 |
Alexander Snow | 14 |
Cathal Friel | 13 |
Kevin Cox | 12 |
Martin Lampshire | 12 |
- Börse
- Insiders
- Martin Gouldstone
- Unternehmensverbindungen